"10.1371_journal.pone.0034313","plos one","2012-03-27T00:00:00Z","Linda Karlsson-Lindahl; Linnéa Schmidt; David Haage; Caroline Hansson; Magdalena Taube; Emil Egeciouglu; Ying-xia Tan; Therese Admyre; John-Olov Jansson; Israel Vlodavsky; Jin-Ping Li; Ulf Lindahl; Suzanne L Dickson","Institute of Neuroscience and Physiology/Endocrinology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Integrative Medical Biology, Section for Physiology, Umeå University, Umeå, Sweden; AstraZeneca, R&D Mölndal, Sweden; Cancer and Vascular Biology Research Center, the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; Department of Medical Biochemistry and Microbiology, University of Uppsala, Uppsala, Sweden","Conceived and designed the experiments: LK-L UL J-PL IV. Performed the experiments: LK-L LS J-PL DH CH MT EE TA Y-XT. Analyzed the data: LK-L LS UL J-PL SD J-OJ. Contributed reagents/materials/analysis tools: UL J-PL IV SD. Wrote the paper: LK-L UL J-PL SD.","The financial support from the commercial funder (Polysackaridforskning AB) involves a patent on heparanase-knockout mice. Author TA is employed by AstraZeneca. Also, funders received from Novo Nordisk Fonden (GeA/AIR). These conditions do not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Linda Karlsson-Lindahl","LKL",13,TRUE,4,9,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
